The Pediatric Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pediatric Gastrointestinal Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacies accounting for % of the Pediatric Gastrointestinal Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pediatric Gastrointestinal Drugs include AstraZeneca, Sanofi, Aptalis, Eisai, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pediatric Gastrointestinal Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Pills
Oral Liquid
Market segment by Application, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by players, this report covers
AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pediatric Gastrointestinal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pediatric Gastrointestinal Drugs, with revenue, gross margin and global market share of Pediatric Gastrointestinal Drugs from 2019 to 2022.
Chapter 3, the Pediatric Gastrointestinal Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pediatric Gastrointestinal Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pediatric Gastrointestinal Drugs research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Pediatric Gastrointestinal Drugs
1.2 Classification of Pediatric Gastrointestinal Drugs by Type
1.2.1 Overview: Global Pediatric Gastrointestinal Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type in 2021
1.2.3 Tablets
1.2.4 Pills
1.2.5 Oral Liquid
1.3 Global Pediatric Gastrointestinal Drugs Market by Application
1.3.1 Overview: Global Pediatric Gastrointestinal Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Pediatric Gastrointestinal Drugs Market Size & Forecast
1.5 Global Pediatric Gastrointestinal Drugs Market Size and Forecast by Region
1.5.1 Global Pediatric Gastrointestinal Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pediatric Gastrointestinal Drugs Market Size by Region, (2017-2022)
1.5.3 North America Pediatric Gastrointestinal Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Pediatric Gastrointestinal Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Pediatric Gastrointestinal Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pediatric Gastrointestinal Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pediatric Gastrointestinal Drugs Market Drivers
1.6.2 Pediatric Gastrointestinal Drugs Market Restraints
1.6.3 Pediatric Gastrointestinal Drugs Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Product and Solutions
2.1.4 AstraZeneca Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Pediatric Gastrointestinal Drugs Product and Solutions
2.2.4 Sanofi Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Aptalis
2.3.1 Aptalis Details
2.3.2 Aptalis Major Business
2.3.3 Aptalis Pediatric Gastrointestinal Drugs Product and Solutions
2.3.4 Aptalis Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Aptalis Recent Developments and Future Plans
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business
2.4.3 Eisai Pediatric Gastrointestinal Drugs Product and Solutions
2.4.4 Eisai Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Eisai Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Pediatric Gastrointestinal Drugs Product and Solutions
2.5.4 Pfizer Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Zeria (Tillotts)
2.6.1 Zeria (Tillotts) Details
2.6.2 Zeria (Tillotts) Major Business
2.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Solutions
2.6.4 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Zeria (Tillotts) Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Solutions
2.7.4 GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Salix Pharmaceuticals
2.8.1 Salix Pharmaceuticals Details
2.8.2 Salix Pharmaceuticals Major Business
2.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Solutions
2.8.4 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.9 Perrigo
2.9.1 Perrigo Details
2.9.2 Perrigo Major Business
2.9.3 Perrigo Pediatric Gastrointestinal Drugs Product and Solutions
2.9.4 Perrigo Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Perrigo Recent Developments and Future Plans
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Pediatric Gastrointestinal Drugs Product and Solutions
2.10.4 Abbott Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Abbott Recent Developments and Future Plans
2.11 Honz Pharmaceutical
2.11.1 Honz Pharmaceutical Details
2.11.2 Honz Pharmaceutical Major Business
2.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.11.4 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Honz Pharmaceutical Recent Developments and Future Plans
2.12 Shandong DYNE Marine Biopharmaceutical
2.12.1 Shandong DYNE Marine Biopharmaceutical Details
2.12.2 Shandong DYNE Marine Biopharmaceutical Major Business
2.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.12.4 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Shandong DYNE Marine Biopharmaceutical Recent Developments and Future Plans
2.13 Sunflower Pharmaceutical
2.13.1 Sunflower Pharmaceutical Details
2.13.2 Sunflower Pharmaceutical Major Business
2.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.13.4 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Sunflower Pharmaceutical Recent Developments and Future Plans
2.14 Jiangzhong Pharmaceutical
2.14.1 Jiangzhong Pharmaceutical Details
2.14.2 Jiangzhong Pharmaceutical Major Business
2.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.14.4 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Jiangzhong Pharmaceutical Recent Developments and Future Plans
2.15 Yabao Pharmaceutical
2.15.1 Yabao Pharmaceutical Details
2.15.2 Yabao Pharmaceutical Major Business
2.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.15.4 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Yabao Pharmaceutical Recent Developments and Future Plans
2.16 Jumpcan Pharmaceutical
2.16.1 Jumpcan Pharmaceutical Details
2.16.2 Jumpcan Pharmaceutical Major Business
2.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.16.4 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
2.17 Hansen Pharmaceutical
2.17.1 Hansen Pharmaceutical Details
2.17.2 Hansen Pharmaceutical Major Business
2.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
2.17.4 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Hansen Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pediatric Gastrointestinal Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pediatric Gastrointestinal Drugs Players Market Share in 2021
3.2.2 Top 10 Pediatric Gastrointestinal Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pediatric Gastrointestinal Drugs Players Head Office, Products and Services Provided
3.4 Pediatric Gastrointestinal Drugs Mergers & Acquisitions
3.5 Pediatric Gastrointestinal Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pediatric Gastrointestinal Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Pediatric Gastrointestinal Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Pediatric Gastrointestinal Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Pediatric Gastrointestinal Drugs Revenue by Type (2017-2028)
6.2 North America Pediatric Gastrointestinal Drugs Revenue by Application (2017-2028)
6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country
6.3.1 North America Pediatric Gastrointestinal Drugs Revenue by Country (2017-2028)
6.3.2 United States Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Pediatric Gastrointestinal Drugs Revenue by Type (2017-2028)
7.2 Europe Pediatric Gastrointestinal Drugs Revenue by Application (2017-2028)
7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country
7.3.1 Europe Pediatric Gastrointestinal Drugs Revenue by Country (2017-2028)
7.3.2 Germany Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
7.3.3 France Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region
8.3.1 Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Region (2017-2028)
8.3.2 China Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8.3.5 India Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Pediatric Gastrointestinal Drugs Revenue by Type (2017-2028)
9.2 South America Pediatric Gastrointestinal Drugs Revenue by Application (2017-2028)
9.3 South America Pediatric Gastrointestinal Drugs Market Size by Country
9.3.1 South America Pediatric Gastrointestinal Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country
10.3.1 Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Pediatric Gastrointestinal Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pediatric Gastrointestinal Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pediatric Gastrointestinal Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pediatric Gastrointestinal Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pediatric Gastrointestinal Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2023-2028)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Pediatric Gastrointestinal Drugs Product and Solutions
Table 9. AstraZeneca Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Pediatric Gastrointestinal Drugs Product and Solutions
Table 13. Sanofi Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Aptalis Corporate Information, Head Office, and Major Competitors
Table 15. Aptalis Major Business
Table 16. Aptalis Pediatric Gastrointestinal Drugs Product and Solutions
Table 17. Aptalis Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Eisai Corporate Information, Head Office, and Major Competitors
Table 19. Eisai Major Business
Table 20. Eisai Pediatric Gastrointestinal Drugs Product and Solutions
Table 21. Eisai Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Pediatric Gastrointestinal Drugs Product and Solutions
Table 25. Pfizer Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Zeria (Tillotts) Corporate Information, Head Office, and Major Competitors
Table 27. Zeria (Tillotts) Major Business
Table 28. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Solutions
Table 29. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Solutions
Table 33. GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Salix Pharmaceuticals Major Business
Table 36. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Solutions
Table 37. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Perrigo Corporate Information, Head Office, and Major Competitors
Table 39. Perrigo Major Business
Table 40. Perrigo Pediatric Gastrointestinal Drugs Product and Solutions
Table 41. Perrigo Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Abbott Corporate Information, Head Office, and Major Competitors
Table 43. Abbott Major Business
Table 44. Abbott Pediatric Gastrointestinal Drugs Product and Solutions
Table 45. Abbott Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Honz Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Honz Pharmaceutical Major Business
Table 48. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 49. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Shandong DYNE Marine Biopharmaceutical Corporate Information, Head Office, and Major Competitors
Table 51. Shandong DYNE Marine Biopharmaceutical Major Business
Table 52. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 53. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Sunflower Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 55. Sunflower Pharmaceutical Major Business
Table 56. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 57. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Jiangzhong Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 59. Jiangzhong Pharmaceutical Major Business
Table 60. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 61. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Yabao Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 63. Yabao Pharmaceutical Major Business
Table 64. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 65. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Jumpcan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 67. Jumpcan Pharmaceutical Major Business
Table 68. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 69. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Hansen Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Hansen Pharmaceutical Major Business
Table 72. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
Table 73. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Pediatric Gastrointestinal Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Pediatric Gastrointestinal Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Pediatric Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Pediatric Gastrointestinal Drugs Players Head Office, Products and Services Provided
Table 78. Pediatric Gastrointestinal Drugs Mergers & Acquisitions in the Past Five Years
Table 79. Pediatric Gastrointestinal Drugs New Entrants and Expansion Plans
Table 80. Global Pediatric Gastrointestinal Drugs Revenue (USD Million) by Type (2017-2022)
Table 81. Global Pediatric Gastrointestinal Drugs Revenue Share by Type (2017-2022)
Table 82. Global Pediatric Gastrointestinal Drugs Revenue Forecast by Type (2023-2028)
Table 83. Global Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022)
Table 84. Global Pediatric Gastrointestinal Drugs Revenue Forecast by Application (2023-2028)
Table 85. North America Pediatric Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Pediatric Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Pediatric Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Pediatric Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Pediatric Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Pediatric Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Pediatric Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Pediatric Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Pediatric Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Pediatric Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Pediatric Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Pediatric Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Pediatric Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Pediatric Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Pediatric Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Pediatric Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pediatric Gastrointestinal Drugs Picture
Figure 2. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Pills
Figure 5. Oral Liquid
Figure 6. Pediatric Gastrointestinal Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Pediatric Gastrointestinal Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Pediatric Gastrointestinal Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
Figure 13. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Region in 2021
Figure 14. North America Pediatric Gastrointestinal Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Pediatric Gastrointestinal Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Pediatric Gastrointestinal Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Pediatric Gastrointestinal Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Pediatric Gastrointestinal Drugs Market Drivers
Figure 20. Pediatric Gastrointestinal Drugs Market Restraints
Figure 21. Pediatric Gastrointestinal Drugs Market Trends
Figure 22. AstraZeneca Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Aptalis Recent Developments and Future Plans
Figure 25. Eisai Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Zeria (Tillotts) Recent Developments and Future Plans
Figure 28. GlaxoSmithKline Recent Developments and Future Plans
Figure 29. Salix Pharmaceuticals Recent Developments and Future Plans
Figure 30. Perrigo Recent Developments and Future Plans
Figure 31. Abbott Recent Developments and Future Plans
Figure 32. Honz Pharmaceutical Recent Developments and Future Plans
Figure 33. Shandong DYNE Marine Biopharmaceutical Recent Developments and Future Plans
Figure 34. Sunflower Pharmaceutical Recent Developments and Future Plans
Figure 35. Jiangzhong Pharmaceutical Recent Developments and Future Plans
Figure 36. Yabao Pharmaceutical Recent Developments and Future Plans
Figure 37. Jumpcan Pharmaceutical Recent Developments and Future Plans
Figure 38. Hansen Pharmaceutical Recent Developments and Future Plans
Figure 39. Global Pediatric Gastrointestinal Drugs Revenue Share by Players in 2021
Figure 40. Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Pediatric Gastrointestinal Drugs Revenue Market Share in 2021
Figure 42. Global Top 10 Players Pediatric Gastrointestinal Drugs Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Pediatric Gastrointestinal Drugs Revenue Share by Type in 2021
Figure 45. Global Pediatric Gastrointestinal Drugs Market Share Forecast by Type (2023-2028)
Figure 46. Global Pediatric Gastrointestinal Drugs Revenue Share by Application in 2021
Figure 47. Global Pediatric Gastrointestinal Drugs Market Share Forecast by Application (2023-2028)
Figure 48. North America Pediatric Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 49. North America Pediatric Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 50. North America Pediatric Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 51. United States Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Pediatric Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 55. Europe Pediatric Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 56. Europe Pediatric Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 57. Germany Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Pediatric Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Pediatric Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
Figure 65. China Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Pediatric Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 72. South America Pediatric Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 73. South America Pediatric Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Pediatric Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Pediatric Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Pediatric Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Pediatric Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Publisher: GlobalInfoResearch
Related Reports
- Global Oncology Based Preclinical CRO Market Analysis and Forecast, 2022-2028
- Global Neurology Clinical Trials Market Analysis and Forecast, 2022-2028
- Global Disposable 3-ply Face Masks Market Analysis and Forecast, 2022-2028
- Global Diabetic Foot Ulcer Therapy Market Analysis and Forecast, 2022-2028
- India Biotechnology Market Analysis and Forecast, 2022-2028
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support